Clinical Trials Database
🇰🇷 South Korea

🇰🇷 South Korea Clinical Trials Database

Search 18,000+ clinical trials conducted in South Korea. Access comprehensive trial data including phases, sponsors, outcomes, and locations from CRIS & International Registries. Part of Pure Global AI's free database with 840,000+ trials worldwide.

Free Database
Powered by Pure Global AI
18,000+ Trials
Search South Korea Clinical Trials
Search 18,000+ clinical trials in South Korea. Enter disease, drug name, sponsor, or trial ID...
Popular searches:
DJ Fang
DJ Fang
MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Frequently Asked Questions
Common questions about the South Korea clinical trials database

What is the South Korea clinical trials database?

The South Korea clinical trials database contains over 18,000 clinical trials registered through CRIS (Clinical Research Information Service) and international registries. South Korea is Asia's fourth-largest pharmaceutical market.

How do I search for clinical trials in South Korea?

Enter a disease name, drug name, sponsor, or trial ID in the search box. You can search in English or Korean.

What regulatory body oversees clinical trials in South Korea?

MFDS (Ministry of Food and Drug Safety) oversees clinical trials in South Korea.

Is this database free to use?

Yes, this database is completely free. Pure Global AI provides free access to help researchers and companies navigate Korean clinical research.

What types of trials are common in South Korea?

South Korea has significant trials in oncology, biologics, and cell/gene therapy. Korea is known for its advanced biotech industry and rapid trial recruitment.

Why include South Korea in global trials?

South Korea offers fast enrollment, high-quality data, and regulatory efficiency. Many global pharma companies include Korean sites in pivotal trials.

About This Database

This database provides free access to clinical trial data from South Korea. South Korea is a major pharmaceutical market with advanced biotech capabilities and efficient clinical trial infrastructure.